Quick answer
Revolution Medicines, Inc. (RVMD) reported diluted EPS of $-3.06 for the quarter ended 2026-06-30, in a 10-Q filed with the SEC on 2026-08-05. Its last four 10-Q/10-K filings were on 2026-08-05, 2026-05-06, 2026-02-25, 2025-11-05.
Data as of 2026-08-05. Source: SEC EDGAR XBRL company facts (10-K/10-Q filings)
| Period end | Period | Form | SEC filing date | Diluted EPS |
|---|---|---|---|---|
| 2026-06-30 | Quarter | 10-Q | 2026-08-05 | $-3.06 |
| 2026-03-31 | Quarter | 10-Q | 2026-05-06 | $-2.29 |
| 2025-12-31 | Full year | 10-K | 2026-02-25 | $-5.95 |
| 2025-09-30 | Quarter | 10-Q | 2025-11-05 | $-1.61 |
| 2025-06-30 | Quarter | 10-Q | 2025-08-06 | $-1.31 |
| 2025-03-31 | Quarter | 10-Q | 2025-05-07 | $-1.13 |
| 2024-12-31 | Full year | 10-K | 2025-02-26 | $-3.58 |
| 2024-09-30 | Quarter | 10-Q | 2024-11-06 | $-0.94 |
| 2024-06-30 | Quarter | 10-Q | 2024-08-07 | $-0.81 |
| 2024-03-31 | Quarter | 10-Q | 2024-05-08 | $-0.70 |
| 2023-12-31 | Full year | 10-K | 2024-02-26 | $-3.86 |
| 2023-09-30 | Quarter | 10-Q | 2023-11-06 | $-0.99 |
| 2023-06-30 | Quarter | 10-Q | 2023-08-08 | $-0.92 |
| 2023-03-31 | Quarter | 10-Q | 2023-05-08 | $-0.72 |
| 2022-12-31 | Full year | 10-K | 2023-02-27 | $-3.08 |
| 2022-09-30 | Quarter | 10-Q | 2022-11-07 | $-0.87 |
Related
- RS earnings report dates and EPS history (Reliance, Inc.)
- RSG earnings report dates and EPS history (Republic Services, Inc.)
- RTX earnings report dates and EPS history (Rtx Corporation)
- RVTY earnings report dates and EPS history (Revvity, Inc)
- S earnings report dates and EPS history (Sentinelone, Inc)
- SAIA earnings report dates and EPS history (Saia, Inc.)
- SAIL earnings report dates and EPS history (SailPoint, Inc.)
- SANM earnings report dates and EPS history (Sanmina Corporation)
Last updated 2026-10-16. Data only, not financial or tax advice.